Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study
Journal article
Nicholson BD. et al, (2023), The Lancet. Oncology, 24, 733 - 743
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A Randomised Controlled Trial.
Journal article
Kelly E. et al, (2023), J Infect
Evaluation of the diagnostic accuracy of two point-of-care tests for COVID-19 when used in symptomatic patients in community settings in the UK primary care COVID diagnostic accuracy platform trial (RAPTOR-C19)
Journal article
Nicholson BD. et al, (2023), PloS one, 18
The early use of Antibiotics for At-risk children with InfluEnza in Primary Care (the ARCHIE programme)
Journal article
Wang K. et al, (2023), Programme Grants for Applied Research, 11, vii - 57
Urine collection devices to reduce contamination in urine samples for diagnosis of uncomplicated UTI: A single-blind randomised controlled trial in primary care
Journal article
Hayward G. et al, (2022), British Journal of General Practice, 72, 1 - 9
The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): A double-blind randomised placebo-controlled trial
Journal article
Wang K. et al, (2021), European Respiratory Journal, 58
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Journal article
Butler CC. et al, (2021), The Lancet Respiratory Medicine, 9, 1010 - 1020
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Journal article
Butler CC. et al, (2021), The Lancet, 397, 1063 - 1074
Association of frequent moisturizer use in early infancy with the development of food allergy.
Journal article
Perkin MR. et al, (2021), J Allergy Clin Immunol, 147, 967 - 976.e1
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Journal article
Yu LM. et al, (2021), The Lancet
Challenges experienced with early introduction and sustained consumption of allergenic foods in the Enquiring About Tolerance (EAT) study: A qualitative analysis.
Journal article
Voorheis P. et al, (2019), J Allergy Clin Immunol, 144, 1615 - 1623
Efficacy of the Enquiring About Tolerance (EAT) study among infants at high risk of developing food allergy.
Journal article
Perkin MR. et al, (2019), J Allergy Clin Immunol, 144, 1606 - 1614.e2
Factors influencing adherence in a trial of early introduction of allergenic food.
Journal article
Perkin MR. et al, (2019), J Allergy Clin Immunol, 144, 1595 - 1605
Dog ownership at three months of age is associated with protection against food allergy
Journal article
Marrs T. et al, (2019), Allergy: European Journal of Allergy and Clinical Immunology, 74, 2212 - 2219
Early use of Antibiotics for at Risk CHildren with InfluEnza (ARCHIE): Protocol for a double-blind, randomised, placebo-controlled trial
Journal article
Wang K. et al, (2018), BMJ Open, 8
Association between domestic water hardness, chlorine, and atopic dermatitis risk in early life: A population-based cross-sectional study
Journal article
Perkin MR. et al, (2016), Journal of Allergy and Clinical Immunology, 138, 509 - 516
Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants.
Journal article
Perkin MR. et al, (2016), N Engl J Med, 374, 1733 - 1743
Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial.
Journal article
Cunningham S. et al, (2015), Lancet, 386, 1041 - 1048